Mutations of TGFβR-II and SMAD4 are rare in NSCLC [95], whereas epidermal growth factor receptor (EGFR) and KRAS mutations are frequently found in lung adenocarcinomas [96]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.